Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis

NATerminatedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

July 31, 2009

Conditions
Atopic Dermatitis
Interventions
OTHER

Formulation 609580 20

Moisturizer, applied topically to whole body, twice a day, morning and evening, after bathing.

OTHER

Formulation 609209 (Lipikar Baume)

Moisturizer, applied topically to whole body, twice a day, morning and evening, after bathing.

Trial Locations (5)

Unknown

The Guenther Dermatology Research Center, London

Lynderm Research, Markham

Innovaderm Research Inc, Laval

Innovaderm Research Inc, Montreal

Centre de recherche dermatologique du Québec Métropolitain, Québec

Sponsors
All Listed Sponsors
collaborator

Innovaderm Research Inc.

OTHER

lead

Cosmetique Active International

INDUSTRY